Achieving graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Achieving graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy
Authors
Keywords
-
Journal
Immunotherapy
Volume 4, Issue 11, Pages 1139-1151
Publisher
Future Medicine Ltd
Online
2012-11-29
DOI
10.2217/imt.12.96
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells
- (2012) F. M. Hofman et al. Anti-Cancer Agents in Medicinal Chemistry
- Reduced-Intensity Allogeneic Stem Cell Transplantation in Children and Young Adults with Ultrahigh-Risk Pediatric Sarcomas
- (2011) Kristin Baird et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
- (2011) Lena von Bahr et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Immunotherapy for glioma
- (2011) Gaetano Finocchiaro et al. CURRENT OPINION IN NEUROLOGY
- The molecular classification of medulloblastoma
- (2011) Sarah E.S. Leary et al. CURRENT OPINION IN PEDIATRICS
- New Perspectives in Glioma Immunotherapy
- (2011) Antonio Daga et al. CURRENT PHARMACEUTICAL DESIGN
- Immunotherapy targeting glioma stem cells – insights and perspectives
- (2011) Zhenhua Li et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The brain tumor microenvironment
- (2011) Nikki A. Charles et al. GLIA
- Cellular immunotherapy for high-grade glioma
- (2011) Kevin KH Chow et al. Immunotherapy
- Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy
- (2011) Mathilde Roger et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
- (2011) Chen-Nen Chang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Stem cells as therapeutic vehicles for the treatment of high-grade gliomas
- (2011) E. Binello et al. NEURO-ONCOLOGY
- Reduced-intensity allogeneic stem cell transplantation for children with neuroblastoma who failed tandem autologous stem cell transplantation
- (2011) Ki Woong Sung et al. PEDIATRIC BLOOD & CANCER
- Crosstalk between Medulloblastoma Cells and Endothelium Triggers a Strong Chemotactic Signal Recruiting T Lymphocytes to the Tumor Microenvironment
- (2011) Vita S. Salsman et al. PLoS One
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Immunotherapy in gliomas: limitations and potential of natural killer (NK) cell therapy
- (2011) Henry Ogbomo et al. TRENDS IN MOLECULAR MEDICINE
- Interleukin-15 Affects Patient Survival through Natural Killer Cell Recovery after Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphomas
- (2010) Luis F. Porrata et al. Clinical & Developmental Immunology
- HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
- (2010) N. Ahmed et al. CLINICAL CANCER RESEARCH
- Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression
- (2010) J. Wei et al. CLINICAL CANCER RESEARCH
- Immune mobilization of autologous blood progenitor cells: direct influence on the cellular subsets collected
- (2010) Kenneth R. Meehan et al. CYTOTHERAPY
- CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs)
- (2010) Janka Held-Feindt et al. EXPERIMENTAL CELL RESEARCH
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity
- (2010) Caroline J Voskens et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A Randomized Controlled Multicenter Study Comparing Recombinant Interleukin 2 (rIL-2) in Conjunction With Recombinant Interferon Alpha (IFN-α) Versus no Immunotherapy for Patients With Malignant Lymphoma Postautologous Stem Cell Transplantation
- (2010) Arnon Nagler et al. JOURNAL OF IMMUNOTHERAPY
- Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
- (2010) Hilko Ardon et al. JOURNAL OF NEURO-ONCOLOGY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is there a role for myeloablative chemotherapy with autologous hematopoietic cell rescue in the management of childhood high-grade astrocytomas?
- (2010) Maura Massimino et al. PEDIATRIC BLOOD & CANCER
- Mesenchymal Stem Cells: A New Promise in Anticancer Therapy
- (2010) Sabino Ciavarella et al. STEM CELLS AND DEVELOPMENT
- Regenerative Stromal Cell Therapy in Allogeneic Hematopoietic Stem Cell Transplantation: Current Impact and Future Directions
- (2009) Jeffery J. Auletta et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
- (2009) Claire Banissi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Applications of neural and mesenchymal stem cells in the treatment of gliomas
- (2009) Thomas Kosztowski et al. Expert Review of Anticancer Therapy
- The role of microglia in central nervous system immunity and glioma immunology
- (2009) Isaac Yang et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Intralesional Lymphokine-activated Killer Cells as Adjuvant Therapy for Primary Glioblastoma
- (2009) Robert Owen Dillman et al. JOURNAL OF IMMUNOTHERAPY
- Genetically engineered T cells to target EGFRvIII expressing glioblastoma
- (2009) Szofia S. Bullain et al. JOURNAL OF NEURO-ONCOLOGY
- Dendritic Cell Vaccines for Brain Tumors
- (2009) Won Kim et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors
- (2008) A Marachelian et al. BONE MARROW TRANSPLANTATION
- Antitumor effect of allogeneic hematopoietic SCT in metastatic medulloblastoma
- (2008) S Secondino et al. BONE MARROW TRANSPLANTATION
- Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy
- (2008) Constantin N. Baxevanis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
- (2008) Robbert G. van der Most et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunogenic anti-cancer chemotherapy as an emerging concept
- (2008) Nicole M Haynes et al. CURRENT OPINION IN IMMUNOLOGY
- Stem and progenitor cell-mediated tumor selective gene therapy
- (2008) K S Aboody et al. GENE THERAPY
- Targeted Cellular Therapy with Natural Killer Cells
- (2008) H. Klingemann et al. HORMONE AND METABOLIC RESEARCH
- Transient T cell depletion causes regression of melanoma metastases
- (2008) Mary Rasku et al. Journal of Translational Medicine
- Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: Outcome compared with conventional chemotherapy: A report from the Children's Oncology Group
- (2008) Jonathan L. Finlay et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started